About: Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 1997 (uk) im März 1997 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 1997 (ast) scientific article published on 01 March 1997 (en)
publication date	wds:Q73115420-E99FF8C8-F9C2-4731-BD32-2541125375F9
publication date	1997-03-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q73115420-FEA6523E-D545-4347-B509-93737377B66C
exact match	https://scigraph.springernature.com/pub.10.1038/sj.bmt.1700687
author name string	wds:Q73115420-14E71C84-EDAE-4C3B-BD42-107590C65DEE wds:Q73115420-49F8945A-E0DC-4C6A-9632-21E2DEA5580D wds:Q73115420-68E9BDD8-F3FF-408B-8306-F4E3F75FFB0D wds:Q73115420-9FD9AC42-8994-40E3-985E-B46B8730C128 wds:Q73115420-B23146AF-93DC-48B8-AB57-50EA0F537136 wds:Q73115420-B42A875C-CFCD-4DD7-AE0B-D51EA2C70A44 wds:Q73115420-B94ED1F0-61AD-4FEE-AC92-A9C7B70B73D5 wds:Q73115420-D9691391-34AB-418C-833B-3F5AD4CAA393 wds:Q73115420-FEF9CA81-18D8-462D-AC46-60178CBE8A74
author name string	N Robinson A York W I Bensinger J A Thompson T Chauncey C Lindgren A Fefer M C Benyunes S Petersdorf
rdfs:label	Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study (en) Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study (nl)
skos:prefLabel	Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study (en) Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study (nl)
name	Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study (en) Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study (nl)
author	wds:Q73115420-4A64F0B7-15FE-4CE0-AD38-32B13BA010A4 wds:Q73115420-6B8C9736-5732-4DD2-9B22-D561D6A0B37C wds:Q73115420-A7E74D81-7F1D-4956-80A6-5E749E5D3173
author	Frederick R. Appelbaum Oliver W Press C. Dean Buckner
title	wds:Q73115420-17EFAF11-40D4-49F0-A050-51D0F08E2375
title	Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study (en)
page(s)	wds:Q73115420-7420091B-CDEB-40AF-9FBC-945484303FFB
page(s)	435-442
instance of	wds:Q73115420-B804B12D-0AB9-4B4D-BA51-53FD91A0AC48
instance of	scholarly article
main subject	wds:Q73115420-11283361-E916-45B7-9E37-99A291A6885E
main subject	stem cell transplantation
PubMed ID	wds:Q73115420-9DE52D0B-C79C-4EF8-A7C1-6AE70503842C
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9052908
PubMed ID	9052908
published in	wds:Q73115420-C64C008C-4E9D-4E58-824C-05FC12F5AED6
published in	Bone Marrow Transplantation
issue	wds:Q73115420-DCB75F05-D7A4-4E63-8511-65EF3163D97B
volume	wds:Q73115420-8ABEFF93-0D2C-461F-901A-4684E085C518
issue	5
volume	19
DOI	wds:Q73115420-FF5061E9-8927-4A91-BD4D-A580571A02C4
DOI	http://dx.doi.org/10.1038/SJ.BMT.1700687
DOI	10.1038/SJ.BMT.1700687
Dimensions Publication ID	wds:Q73115420-C6EECEAD-563F-4EE5-B1E7-BF5D8F9ED16F
Dimensions Publication ID	1028744257
PMCID	wds:Q73115420-07A2C6AB-C864-41C1-A65A-4A083DC4E208
PMCID	7092324
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73115420
is cites work of	Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia. Eastern Cooperative Oncology Group Cytokine modulation of the innate immune system in the treatment of leukemia and lymphoma The biology of natural killer cells in cancer, infection, and pregnancy Complete remission of tumour with interleukin 2 therapy in a patient with non-Hodgkin's lymphoma post allogeneic bone marrow transplant associated with polyclonal T-cell bone marrow lymphocytosis Outcome and long-term follow-up of alloreactive donor lymphocyte infusions given for relapse after myeloablative allogeneic hematopoietic stem cell transplantations (HSCT). IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial. Vaccination regimens incorporating CpG-containing oligodeoxynucleotides and IL-2 generate antigen-specific antitumor immunity from T-cell populations undergoing homeostatic peripheral expansion after BMT. Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 ra Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II study Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer NK cell therapy for hematologic malignancies. Autologous hematopoietic cell transplantation in non-Hodgkin's lymphoma Early recovery of aggressive cytotoxic cells and improved immune resurgence with post-transplant immunotherapy for multiple myeloma New approaches to hematopoietic cell transplantation in oncology Post-transplant immunotherapy designed to prevent cancer recurrence
is cites work of	wds:Q40371959-02B45E64-91AC-4C5A-99C9-1AE141CDE567 wds:Q78967000-DEA0B9E5-0ABF-491F-9ED9-443D1313192C wds:Q49566331-257B686B-5111-476C-8EFD-174CC1242536 wds:Q40752551-9B17E2EC-BFCD-4DB0-9662-7DCC7D9248DC wds:Q73409370-F0A4BFD4-9D25-4C22-9AC8-B11F57F1E7CA wds:Q33769671-C905E5F9-79AB-4139-B315-6845021C205B wds:Q46366067-13C89F51-6FBC-453A-9901-87491C66C050 wds:Q73399801-FB7FAEB5-DE13-4F13-9EB4-9D30F1BC9A18 wds:Q33788224-6BE64821-9C29-4240-BEA2-33314A7A2232 wds:Q80119050-5DB5DB91-64DE-4FE5-B163-64EFCD893194 wds:Q35909326-2687F101-FFB7-472A-9720-C4009F6875CF wds:Q53925120-2EF4387D-74A7-45D2-93D1-5E7B03D5356C wds:Q35064139-C058AD12-6057-4B94-AE16-EB4718305E18 wds:Q35850723-F7C2F332-85D2-4EEE-807A-3F583B5B5F4A wds:Q34402067-DB313CC6-3A75-456C-B69B-A774CA4E59F8 wds:Q30481608-B99CCEBD-8055-40CE-8C1A-C85FEEE0F5C8

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 170 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software